EU approves Danish plan to put EUR 108m behind Bavarian Nordic's Covid-19 vaccine

The Danish state's plan to award EUR 108m to support phase III studies of Bavarian Nordic's covid-19 vaccine has been approved by the EU Commission.

Photo: Philip Davali/Ekstra Bladet

The EU Commission, which works alongside competition authorities from member states, announced on Monday that it will allow the Danish state to offer Bavarian Nordic EUR 108m to support the development of its Covid-19 vaccine.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs